RT Journal Article
SR Electronic
T1 Depression Incidence in Patients with Hypertension in a Single Outpatient Center
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.24.24314333
DO 10.1101/2024.09.24.24314333
A1 Amoateng, Richard
A1 Arunthamakun, Natthew
A1 Tierliwaerdi, Xiarepati
A1 Johnston, Alexandra
A1 Gadani, Mrudula
YR 2024
UL http://medrxiv.org/content/early/2024/09/26/2024.09.24.24314333.abstract
AB Introduction Hypertension and depression are both highly prevalent in the United States and each condition is commonly managed in the outpatient setting. This study aims to investigate the incidence of depression in patients who are diagnosed with hypertension.Methods A retrospective cohort study was conducted analyzing 9,240 adult patients at a single center outpatient clinic between 2019 and 2022. Blood pressure and PHQ-9 from the latest outpatient visit were recorded. Demographic data associated with hypertension were also obtained. Bivariate statistical analysis was performed. Multivariate linear and logistic regression models were adjusted for co-morbid conditions.Results Out of the 9,240 patients studied, 3,694 (40%) had a diagnosis of hypertension. Patients with hypertension were more likely to be older (61.96 ± 14.95 vs 39.85 ± 15.61, p=0.000), male (37% vs 33%, p =0.002) and black (45.2% vs 23.3%, p<0.001) compared with those without a diagnosis of hypertension. The mean PHQ-9 score was higher in patients with hypertension than in those without (2.97 ±4.66 vs 2.70 ± 4.93, p=0.000). Patients with hypertension were more likely to have uncontrolled depression defined as PHQ-9 score >4 (22.55% vs 19.4%, p<0.001) even when adjusted for co-morbid conditions (adj OR 1.216 95% CI 1.06 -1.34 p=0.005).Conclusions In this cohort of patients, a diagnosis of hypertension was associated with an increased rate of uncontrolled depressive symptoms. Hence patients with hypertension should be screened using validated PHQ-9 tools in the outpatient setting and offered appropriate treatment for depression.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementNo external funding receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board at Allegheny Health Network.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data are available upon requestCHFongestive heart failureCLDchronic liver diseaseCKDchronic kidney diseaseCOPDchronic obstructive pulmonary diseaseHTNhypertensionPHQpatient health questionnaire